logo
Share SHARE
FONT-SIZE Plus   Neg

Covidien Gets FDA 510(k) Clearance For LigaSure Small Jaw, Open Sealer/divider

Covidien Ltd. (COV) said it secured 510(k) clearance from the U.S. Food and Drug Administration, or FDA, for the LigaSure curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat procedures.

According to the company, when working in confined surgical spaces, the proprietary LigaSure device addresses surgeons' needs by offering a low-temperature profile and minimal thermal spread to surrounding tissues. The LigaSure small jaw instrument provides an integrated cutting mechanism independent of sealing, leaving critical cutting decisions in the surgeon's hands.

In addition, LigaSure small jaw instrument's multifunctional design provides for blunt dissection and an enhanced experience for the surgeon, especially in confined surgical spaces. LigaSure technology, powered by the ForceTriad energy platform, gives surgeons a continuous output of energy, monitoring the tissue and making real-time adjustments 3,333 times/second to seal vessel walls.

Covidien noted that the new clearance, for the device's use in head and neck procedures, will allow for additional uses such as thyroidectomies, parotidectomies and additional open ENT procedures.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Crypto Co., engaged in the digital currencies and blockchain sector, announced its plans to execute a 10-for-1 stock split, citing the significant growth in the value and demand for its shares amid the ongoing digital currency market boost. CEO Mike Poutre said, ""We are aware of the recent fluctuation in our stock, and want to see orderly market activity surrounding the trading of our stock." Teva Pharmaceutical Industries Ltd. (TEVA) said Thursday that it plans to reduce 14,000 jobs globally or more than 25% of its total workforce in the next two years. It will immediately suspend dividends on ordinary shares, and cancel bonus for 2017. The company will continue to review the potential for additional divestment of non-core assets. Checkout the few notable companies that are scheduled to release quarterly financial results on Thursday, December 14, 2017. - Growing Cloud Footprint To Bolster ADBE Q4 - COST Q1 Likely To Benefit From Holiday Weekend Sales - Growth And Diversification Strategy To Boost JBL Q1 Results - Will Cloud Propel ORCL Quarterly Performance?
comments powered by Disqus
Follow RTT